BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9385933)

  • 1. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
    Felgar RE; Steward KR; Cousar JB; Macon WR
    Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors.
    Medema JP; de Jong J; Peltenburg LT; Verdegaal EM; Gorter A; Bres SA; Franken KL; Hahne M; Albar JP; Melief CJ; Offringa R
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11515-20. PubMed ID: 11562487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.
    Leung W; Iyengar R; Leimig T; Holladay MS; Houston J; Handgretinger R
    Cancer Immunol Immunother; 2005 Apr; 54(4):389-94. PubMed ID: 15449041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer.
    Kishi A; Takamori Y; Ogawa K; Takano S; Tomita S; Tanigawa M; Niman M; Kishida T; Fujita S
    Cancer Immunol Immunother; 2002 Jan; 50(11):604-14. PubMed ID: 11807624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2.
    Leger-Ravet MB; Mathiot C; Portier A; Brandely M; Galanaud P; Fridman WH; Emilie D
    Cancer Immunol Immunother; 1994 Jul; 39(1):53-8. PubMed ID: 8044827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential.
    Hsu H; Zanettini C; Coker M; Boudova S; Rach D; Mvula G; Divala TH; Mungwira RG; Boldrin F; Degiacomi G; Mazzabò LC; Manganelli R; Laufer MK; Zhang Y; Marchionni L; Cairo C
    Cell Immunol; 2024; 395-396():104797. PubMed ID: 38157646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional Events Orchestrate Immune Homeostasis of CD8
    Freen-van Heeren JJ
    Methods Mol Biol; 2024; 2782():65-80. PubMed ID: 38622392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication Stress in Activated Human NK Cells Induces Sensitivity to Apoptosis.
    Guilz NC; Ahn YO; Fatima H; Pedroza LA; Seo S; Soni RK; Wang N; Egli D; Mace EM
    J Immunol; 2024 Jul; 213(1):40-51. PubMed ID: 38809096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perforin: an important player in immune response.
    Osińska I; Popko K; Demkow U
    Cent Eur J Immunol; 2014; 39(1):109-15. PubMed ID: 26155110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles From the Human Natural Killer Cell Line NK3.3 Have Broad and Potent Anti-Tumor Activity.
    Cochran AM; Kornbluth J
    Front Cell Dev Biol; 2021; 9():698639. PubMed ID: 34368150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of mature T- and NK-cell lymphomas.
    Jia J; Wang X; Song Z; Meng S; Fei Y; Yu J; Liu X; Han X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Wang X; Zhang H
    Cancer Biol Med; 2024 Mar; 21(3):223-9. PubMed ID: 38544483
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.
    Bochicchio A; Jordaan S; Losasso V; Chetty S; Perera RC; Ippoliti E; Barth S; Carloni P
    Biomedicines; 2017 Feb; 5(1):. PubMed ID: 28536352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56-negative primary natural killer T-cell lymphoma of the testis: A case report and the literature review.
    Liu L; Wang KJ; Wang Q; An L
    Asian J Surg; 2024 Jun; ():. PubMed ID: 38862299
    [No Abstract]   [Full Text] [Related]  

  • 14. Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.
    Pongpruttipan T; Kummalue T; Bedavanija A; Khuhapinant A; Ohshima K; Arakawa F; Niino D; Sukpanichnant S
    Diagn Pathol; 2011 Aug; 6():79. PubMed ID: 21867533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology.
    Metgud RS; Doshi JJ; Gaurkhede S; Dongre R; Karle R
    J Oral Maxillofac Pathol; 2011 Jan; 15(1):96-100. PubMed ID: 21731288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
    Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
    J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
    Ng CS; Lo ST; Chan JK; Chan WC
    Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of cytotoxic molecules in CD8- and/or CD56-positive adult T-cell leukaemia/lymphoma.
    Ohshima K; Haraoka S; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):101-4. PubMed ID: 10599307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
    Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
    Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.